Literature DB >> 11381301

Acute hepatitis induced by alpha-interferon in a patient with chronic hepatitis C.

I Kraus1, D Vitezic.   

Abstract

Hepatic adverse effects occur very rarely with alpha-interferon therapy. A case of acute hepatitis induced by alpha-interferon in a 33-year-old man with chronic hepatitis C is described. The patient developed acute hepatitis with very high aminotransferase activity and jaundice. After discontinuing alpha-interferon therapy, hepatitis resolved rapidly. The immune-mediated mechanism is the most probable cause of this hepatitis.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11381301     DOI： 10.1155/2001/510742

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN： 0835-7900            Impact factor:   3.522


  2 in total

1.  Severe liver injury associated with simeprevir plus pegylated interferon/ribavirin therapy in a patient with treatment-naïve genotype 1b hepatitis C virus: a case report.

Authors:  Takuro Igawa; Soichiro Fushimi; Ryuichi Matsuo; Fusao Ikeda; Kazuhiro Nouso; Tadashi Yoshino; Harushige Nakatsukasa
Journal:  Clin J Gastroenterol       Date:  2014-08-27

2.  Peginterferon alfa-2a is associated with elevations in alanine aminotransferase at the end of treatment in chronic hepatitis C patients with sustained virologic response.

Authors:  Chih-Wei Tseng; Chi-Yi Chen; Ting-Tsung Chang; Shinn-Jia Tzeng; Yu-Hsi Hsieh; Tsung-Hsing Hung; Ching-Chih Lee; Shu-Fen Wu; Kuo-Chih Tseng
Journal:  PLoS One       Date:  2014-06-17       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.